QJI — Interoperable Automated Glycemic Controller Class II

FDA Device Classification

FDA product code QJI covers "Interoperable Automated Glycemic Controller", a Class II medical device regulated under 21 CFR 862.1356. Submissions are reviewed by the Clinical Chemistry panel. At least 20 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
QJI
Device Class
Class II
Regulation Number
862.1356
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K261962medtronic minimedSmartGuard Technology; Predictive Low Glucose TechnologyJuly 9, 2026
K261461insulet corporationOmnipod 6 algorithmJune 29, 2026
K260429tandem diabetes careControl-IQ+ technologyApril 24, 2026
K253701medtronic minimedSmartGuard Technology; Predictive Low Glucose TechnologyFebruary 3, 2026
K253585medtronic minimedSmartGuard technology; Predictive Low Glucose technologyJanuary 14, 2026
K251152diabeloopDBLG2December 19, 2025
K251779insulet corporationOmnipod 5 algorithmDecember 3, 2025
K251217medtronic minimedSmartGuard technology; Predictive Low Glucose technologyAugust 29, 2025
K250798tandem diabetes careControl-IQ+ technologyMay 21, 2025
K243823tandem diabetes careControl-IQ+ technologyFebruary 24, 2025
K241777insulet corporationSmartAdjust™ TechnologyAugust 26, 2024
K232741insulet corporationSmartAdjust(TM) technologyMay 29, 2024
K232603camdiabCamAPS FXMay 23, 2024
K234055deka research and developmentDEKA LoopMarch 13, 2024
K232382tandem diabetes careControl-IQ TechnologyNovember 3, 2023
K232224beta bionicsiLet® Dosing Decision SoftwareSeptember 22, 2023
K220916beta bionicsiLet® Dosing Decision SoftwareMay 19, 2023
K203689tidepool projectTidepool LoopJanuary 23, 2023
K220394insulet corporationSmartAdjust(TM) technologyAugust 19, 2022
K203774insulet corporationSmartAdjust technologyJanuary 27, 2022